• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Medicaid, with planned payment pilot, girds for influx of pricey gene therapies

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Feb 21, 2023 at 04:52: PM
via People with the blood disorder sickle cell are anticipating the arrival of two gene therapies that could dramatically reshape their disease, potentially offering something approaching a cure.

article source
 




Top Bottom
Back
Quote